Health Condition 1: D509- Iron deficiency anemia, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: a. Haemoglobin level between 6 and 10 gm/dl b. Presence of any four of the following clinical findings i. Serum Iron content below 50 µg/l ii. Serum Ferritin below 30 µg/l iii. Haematocrit/ PCV below 35% iv. TIBC below 200 µg/l v. MCHC level below 34 g/dl vi. MCV level below 80 fl vii. Peripheral blood smear showing Hypochromic & Microcytic Anaemia
Exclusion criteria
Exclusion criteria: a. Pregnant Women & Lactating Mothers b. Severe Renal, Hepatic & Cardiac diseases c. Known case of Diabetes mellitus & Hypertension d. Other clinical conditions like Bleeding Piles, Haemetemesis, Maleana etc, Causing frequent blood loss e. Dimorphic Anaemia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| i. Safety and Efficacy of the trial drug Thiriloga Chenduram ii. Biochemical changes in Blood and RBC (Before and After treatment)Timepoint: Laboratory Investigations will be performed on 0th, 15th, 30th & 46th day. | — |
Secondary
| Measure | Time frame |
|---|---|
| iii. Substantiate the prognosis of the patient even after therapyTimepoint: Blood investigations will be done on 1st, 3rd and 6th month after the treatment period of 45 days. | — |
Countries
India
Contacts
Siddha Regional Research Institute, (Under CCRS, Ministry of AYUSH)